Clinical trial
PathToScale: An Implementation Evaluation
NCT06319105
Study timeline
Study start (actual)2024-03-26Date precision: day
Registry last updated2024-03-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Oral Pre-exposure Prophylaxis (PrEP)unresolved
Interventions
Sponsors & collaborators
Georgetown Universitylead sponsor
AIDS Vaccine Advocacy Coalitioncollaborator
Centers for Disease Control and Preventioncollaborator
Center for the Development of Peoplecollaborator
Cooper/Smithcollaborator
Elizabeth Glaser Pediatric AIDS Foundationcollaborator
Family Health Servicescollaborator
Healthqualcollaborator
Johns Hopkins Research Project, Malawicollaborator
Johns Hopkins Bloomberg School of Public Healthcollaborator
Kamuzu University of Health Sciencescollaborator
Blantyre District Health Office, Malawicollaborator
Lilongwe District Health Office, Malawicollaborator
Lighthouse Trustcollaborator
Ministry of Health, Malawicollaborator
National AIDS Commission, Malawicollaborator
Partners in Hope, Inc.collaborator
Population Services Internationalcollaborator
University of North Carolinacollaborator
Quantitative Engineering Designcollaborator
Clinton Health Access Initiative-Malawicollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06319105 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.